Robert S. Landsman

Array ( [id] => 6347043 [patent_doc_number] => 20100330591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'GPCR Expressing Cell Lines and Antibodies' [patent_app_type] => utility [patent_app_number] => 12/820987 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25964 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330591.pdf [firstpage_image] =>[orig_patent_app_number] => 12820987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382727 [patent_doc_number] => 20100316992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'DIAGNOSTIC TEST' [patent_app_type] => utility [patent_app_number] => 12/818093 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13297 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316992.pdf [firstpage_image] =>[orig_patent_app_number] => 12818093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8126767 [patent_doc_number] => 20120087935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'SERINE RICH PEPTIDES HAVING ANTIOXIDATIVE STRESS PROPERTIES' [patent_app_type] => utility [patent_app_number] => 13/377431 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8594 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20120087935.pdf [firstpage_image] =>[orig_patent_app_number] => 13377431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9888974 [patent_doc_number] => 08975229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Methods for treating a disease caused by choroidal neovascularization' [patent_app_type] => utility [patent_app_number] => 13/377110 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16157 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 512 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10007864 [patent_doc_number] => 09051368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23' [patent_app_type] => utility [patent_app_number] => 12/813303 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 46564 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12813303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614542 [patent_doc_number] => 20100310509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/794368 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20302 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310509.pdf [firstpage_image] =>[orig_patent_app_number] => 12794368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580305 [patent_doc_number] => 20110294188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Ideotypically Modulated Pharmacoeffectors For Selective Cell Treatment' [patent_app_type] => utility [patent_app_number] => 12/790931 [patent_app_country] => US [patent_app_date] => 2010-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7845 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294188.pdf [firstpage_image] =>[orig_patent_app_number] => 12790931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817390 [patent_doc_number] => 20120064010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration' [patent_app_type] => utility [patent_app_number] => 13/322087 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7642 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064010.pdf [firstpage_image] =>[orig_patent_app_number] => 13322087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054167 [patent_doc_number] => 20120076787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'COMBINATION OF A TNF-ALPHA ANTAGONIST AND A VEGF ANTAGONIST FOR USE IN THE TREATMENT OR PREVENTION OF DISEASES OF THE EYE' [patent_app_type] => utility [patent_app_number] => 13/322213 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41270 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076787.pdf [firstpage_image] =>[orig_patent_app_number] => 13322213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817474 [patent_doc_number] => 20120064094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Serotonin 5-HT3 Receptor Antagonists for Use in the Treatment of Lesional Vestibular Disorders' [patent_app_type] => utility [patent_app_number] => 13/321493 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12396 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064094.pdf [firstpage_image] =>[orig_patent_app_number] => 13321493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992981 [patent_doc_number] => 20110014634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'NUCLEIC ACIDS ENCODING T2R, A NOVEL FAMILY OF TASTE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/772804 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 34108 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014634.pdf [firstpage_image] =>[orig_patent_app_number] => 12772804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977708 [patent_doc_number] => 20110071085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'USE OF SURVIVIN TO TREAT KIDNEY FAILURE' [patent_app_type] => utility [patent_app_number] => 12/769158 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10230 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071085.pdf [firstpage_image] =>[orig_patent_app_number] => 12769158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6526595 [patent_doc_number] => 20100203556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY' [patent_app_type] => utility [patent_app_number] => 12/765406 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 63097 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203556.pdf [firstpage_image] =>[orig_patent_app_number] => 12765406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509025 [patent_doc_number] => 20100210666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY' [patent_app_type] => utility [patent_app_number] => 12/765414 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 63053 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210666.pdf [firstpage_image] =>[orig_patent_app_number] => 12765414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355317 [patent_doc_number] => 20100249757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Method of Electrogenically Controlling Pump Molecules' [patent_app_type] => utility [patent_app_number] => 12/762708 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16665 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249757.pdf [firstpage_image] =>[orig_patent_app_number] => 12762708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8187157 [patent_doc_number] => 20120116060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Blockers of NMDA Receptor for the Treatment of Sickle Cell Anemia' [patent_app_type] => utility [patent_app_number] => 13/265709 [patent_app_country] => US [patent_app_date] => 2010-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3030 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116060.pdf [firstpage_image] =>[orig_patent_app_number] => 13265709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7732417 [patent_doc_number] => 20120015397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Periodontal Disease Marker (as amended herewith)' [patent_app_type] => utility [patent_app_number] => 13/258700 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5206 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015397.pdf [firstpage_image] =>[orig_patent_app_number] => 13258700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056029 [patent_doc_number] => 20120077731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST IL-6R AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF IL-6R RELATED DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/263179 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 89 [patent_no_of_words] => 90512 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077731.pdf [firstpage_image] =>[orig_patent_app_number] => 13263179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323739 [patent_doc_number] => 08658762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/263702 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11617 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007078 [patent_doc_number] => 20110059109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Methods for inducing or enhancing an immune response by administering GITR-binding antibodies' [patent_app_type] => utility [patent_app_number] => 12/753402 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33794 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059109.pdf [firstpage_image] =>[orig_patent_app_number] => 12753402 [rel_patent_id] =>[rel_patent_doc_number] =>)